Department of Cardiovascular Surgery, Hotel Dieu de France Hospital, Beirut, Lebanon.
Int J Cardiol. 2009 Oct 2;137(2):116-22. doi: 10.1016/j.ijcard.2008.06.034. Epub 2008 Aug 9.
Postoperative atrial fibrillation (AF) occurs in up to 50% of patients undergoing coronary artery bypass (CABG) surgery and is associated with complications. Amiodarone and beta blockers are effective as prophylaxis for AF after CABG. The purpose of this study was to compare oral amiodarone versus oral bisoprolol for prevention of AF after CABG.
In this randomized study, 200 patients admitted for elective CABG were given oral amiodarone (n=98 patients) or oral bisoprolol (n=102 patients) beginning 6 h after surgery. Amiodarone patients received 15 mg/Kg then 7 mg/Kg/day for one month. Bisoprolol patients received 2.5 mg then 2.5 mg bid indefinitely.
Postoperative AF occurred in 15.3% of the patients in the amiodarone group and 12.7% of the patients in the bisoprolol group (p=0.60). Maximal ventricular rate tended to be lower in the bisoprolol group (125+/-6 beats/min) compared with the amiodarone group (144+/-7 beats/min, p=.06). Preoperative beta blockage did not affect AF incidence in either study group. There was no difference between the 2 groups for the onset time of AF episodes, total AF duration, AF recurrence and postoperative length of hospital stay. No serious postoperative complications occurred in the two study groups. Two reversible low cardiac output cases occurred with bisoprolol.
Postoperative oral bisoprolol and amiodarone are equally effective for prophylaxis of AF after CABG. Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases. Both regimens were well tolerated.
冠状动脉旁路移植术(CABG)术后心房颤动(AF)的发生率高达 50%,并与并发症有关。胺碘酮和β受体阻滞剂是 CABG 后预防 AF 的有效药物。本研究的目的是比较口服胺碘酮与口服比索洛尔预防 CABG 后 AF 的效果。
在这项随机研究中,200 例择期 CABG 患者术后 6 小时开始口服胺碘酮(n=98 例)或比索洛尔(n=102 例)。胺碘酮组患者给予 15mg/Kg,然后每天 7mg/Kg,持续 1 个月。比索洛尔组患者给予 2.5mg,然后每天 2 次,每次 2.5mg,无限期服用。
胺碘酮组 15.3%的患者发生术后 AF,比索洛尔组 12.7%的患者发生术后 AF(p=0.60)。比索洛尔组的最大心室率(125+/-6 次/分)较胺碘酮组(144+/-7 次/分,p=0.06)低。在两个研究组中,术前β阻滞剂均不影响 AF 的发生率。两组间 AF 发作的起始时间、总 AF 持续时间、AF 复发和术后住院时间均无差异。两组均未发生严重的术后并发症。比索洛尔组有 2 例可逆性低心输出量。
术后口服比索洛尔和胺碘酮预防 CABG 后 AF 的效果相当。比索洛尔治疗组 AF 病例的心室反应率呈下降趋势。两种方案均耐受良好。